Pseudoephedrine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pseudoephedrine Hydrochloride
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Pseudoephedrine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 25 USDMF, 10 CEP/COS, 1 JDMF, 3 EU WC, 6 KDMF, 12 NDC API, 13 Listed Suppliers, $ API Reference Price

39 API Suppliers
25 USDMF
10 CEP/COS
1 JDMF
3 EU WC
6 KDMF
12 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

311 FDF Dossiers, 112 FDA Orange Book, 3 Europe, 114 Canada, 48 South Africa, 34 Listed Dossiers

311 FDF Dossiers
112 FDA Orange Book
3 Europe
114 Canada
48 South Africa
34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - 8MG;60MG, TABLET, EXTENDED RELEASE;ORAL - 240MG, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG, TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

TABLET;ORAL - 200MG;30MG
CAPSULE;ORAL - 8MG;60MG
TABLET, EXTENDED RELEASE;ORAL - 240MG
TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG
CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG
TABLET;ORAL - 2MG;200MG;30MG
TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG
TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG
TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG
SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML
SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 9 Rochem International Inc, 22 SPI Pharma, 15 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 12 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 9 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 15 Actylis, 4 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 38 BASF, 1 Bioplus Life Sciences, 2 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 18 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 10 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 37 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

121 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 48 Direct Compression, 47 Disintegrants & Superdisintegrants, 46 Thickeners and Stabilizers, 41 Controlled & Modified Release, 37 Granulation, 37 Taste Masking, 36 Solubilizers, 34 Film Formers & Plasticizers, 32 Topical, 29 Lubricants & Glidants, 28 Parenteral, 25 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 11 Rheology Modifiers, 10 API Stability Enhancers, 10 Emulsifying Agents, 9 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

121 Fillers, Diluents & Binders
63 Coating Systems & Additives
48 Direct Compression
47 Disintegrants & Superdisintegrants
46 Thickeners and Stabilizers
41 Controlled & Modified Release
37 Granulation
37 Taste Masking
36 Solubilizers
34 Film Formers & Plasticizers
32 Topical
29 Lubricants & Glidants
28 Parenteral
25 Chewable & Orodispersible Aids
19 Co-Processed Excipients
11 Rheology Modifiers
10 API Stability Enhancers
10 Emulsifying Agents
9 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 31 News #PharmaBuzz

1 Data Compilation #PharmaFlow
31 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

1 Regulatory FDF Prices

MARKET PLACE

25 APIs

25 APIs

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

1 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 53 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1HALEON US HOLDINGS

filter Patent Number Reset all filters

1 All

01 17863287

filter API Patent Reset all filters

1 All

01 1Blank

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12027-02-28

Product Main Page

01

HALEON US HOLDINGS

CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

HALEON US HOLDINGS

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-02-28

CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

US Patent Number : 7863287

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21441

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-02-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!